retatrutide phase 2 nejm 2023 obesity trial jastreboff π may be redefining treatment. New data from TRIUMPH-1 showed: π₯ ~28% average weight loss over 80 weeks π₯ >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Early trial data for retatrutide
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Oct 31 - Nov 5



:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)

%20(1).png)



















